(Q38230839)

English

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial

scientific article published on 15 July 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 August 2017

Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial (English)

1 reference

Europe PubMed Central

31 August 2017

phase III clinical trial

0 references

0 references

zoledronic acid

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Caroline Wilson

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Peter Barrett-Lee

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Samantha Hinsley

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Robert Coleman

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

David Cameron

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

David Dodwell

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Richard Bell

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Emma Rathbone

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Maccon Keane

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Miguel Gil

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Roger Burkinshaw

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Robert Grieve

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Diana Ritchie

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Victoria Liversedge

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

AZURE investigators

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 July 2014

1 reference

Europe PubMed Central

31 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

997-1006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Preparing the "soil": the premetastatic niche

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer to bone: a fatal attraction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of bone metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of bone-targeted agents on cancer progression and mortality.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast-cancer adjuvant therapy with zoledronic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of oral clodronate on bone mass, bone turnover and subsequent metastases in women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01/04).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow: a long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisphosphonate treatment in primary breast cancer: results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone turnover across the menopause transition : The role of gonadal inhibins.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970302-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)70302-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

10.1016/S1470-2045(14)70302-X

0 references

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25035292%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

2-s2.0-84905007644

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38230839&oldid=1748717024"